Menu
Search
|

Menu

Close
X

Sumitomo Dainippon Pharma Co Ltd 4506.T (Tokyo Stock Exchange)

2,763.00 JPY
-8.00 (-0.29%)
As of Mar 22
chart
Previous Close 2,771.00
Open 2,745.00
Volume 1,775,400
3m Avg Volume 2,079,494
Today’s High 2,767.00
Today’s Low 2,668.00
52 Week High 4,135.00
52 Week Low 1,654.00
Shares Outstanding (mil) 397.90
Market Capitalization (mil) 1,099,398.00
Forward P/E 22.17
Dividend (Yield %) 9.00 ( 0.65 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.60 Mean rating from 10 analysts

KEY STATS

Revenue (mm, JPY)
FY19
346,871
FY18
466,838
FY17
713,864
FY16
403,206
EPS (JPY)
FY19
100.602
FY18
134.528
FY17
153.252
FY16
62.162
*Note: Units in Millions of Yen
**Note: Units in Yen

KEY RATIOS

Price to Earnings (TTM)
vs sector
22.17
58.10
Price to Sales (TTM)
vs sector
2.40
8.84
Price to Book (MRQ)
vs sector
2.20
4.60
Price to Cash Flow (TTM)
vs sector
17.32
40.07
Total Debt to Equity (MRQ)
vs sector
6.36
17.66
LT Debt to Equity (MRQ)
vs sector
5.77
13.97
Return on Investment (TTM)
vs sector
7.72
12.12
Return on Equity (TTM)
vs sector
9.76
13.24

EXECUTIVE LEADERSHIP

Masayo Tada
Chairman of the Board, Representative Director, Since 2018
Salary: --
Bonus: --
Hiroshi Nomura
President, Representative Director, Since 2018
Salary: --
Bonus: --
Hitoshi Odagiri
Managing Executive Officer, Chief Director of Sales, Head of Japan Business Unit, Director, Since 2018
Salary: --
Bonus: --
Yoshiharu Ikeda
Managing Executive Officer, Chief Director of Production, Deputy Head of Japan Business Unit, Since 2017
Salary: --
Bonus: --
Kazuo Koshiya
Managing Executive Officer, Global Head of Oncology, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

2-6-8, Dosho-machi, Chuo-ku
OSAKA-SHI   OSK   541-0045

Phone: +816.62035321

Sumitomo Dainippon Pharma Co., Ltd., is a pharmaceutical company. The Japan segment manufactures and sells ethical and general use drugs. The North America segment manufactures, develops, purchases and sells ethical drugs. The China segment manufactures and sells ethical drugs through its consolidated subsidiary. The Other Overseas division is involved in the development of its products in Europe. The Company is also engaged in the manufacture, purchase, sale and supply of food materials and additives, chemical products, veterinary drugs, diagnostic products and inspection services of clinical pathology for animal, the manufacture of extracts, as well as the storage, delivery and clinical inspection of drugs.

SPONSORED STORIES